Martin H. Huber Jr. Syndax Pharmaceuticals Inc (SNDX) insider trading activity

SNDX Quotes by TradingView

Martin H. Huber Jr. is of Syndax Pharmaceuticals Inc. Currently has a direct ownership of 49,000 shares of SNDX, which is worth approximately $1.11 Million. The most recent transaction as insider was on Feb 07, 2024, when has been sold 17,000 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 49K
0% 3M change
53.13% 12M change
Total Value Held $1.11 Million

Martin H. Huber Jr. Transaction History

Date Transaction Value Shares Traded Shares Held Form
Feb 07 2024
BUY
Grant, award, or other acquisition
-
17,000 Added 25.76%
49,000 Common Stock
Feb 02 2023
BUY
Grant, award, or other acquisition
-
16,000 Added 33.33%
32,000 Common Stock
Feb 02 2022
BUY
Grant, award, or other acquisition
-
16,000 Added 50.0%
16,000 Common Stock

Also insider at

MRSN
Mersana Therapeutics, Inc. Healthcare
President, CEO
XLO
Xilio Therapeutics, Inc. Healthcare
PRESIDENT AND HEAD OF R&D
MHH

Martin H. Huber Jr.

Waltham, MA

Track Institutional and Insider Activities on SNDX

Follow Syndax Pharmaceuticals Inc and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells SNDX shares.

Notify only if

Insider Trading

Get notified when an Syndax Pharmaceuticals Inc insider buys or sells SNDX shares.

Notify only if

News

Receive news related to Syndax Pharmaceuticals Inc

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on SNDX